Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Catalyst Grant: Sex as a Variable in Biomedical Research

University of Guelph

$149,358.00

Sex and the Ageing Heart: The molecular basis for the functional decline and development of a novel therapeutic target

EF 2015-16

Résumé
Females have lower rates of heart failure compared to age-matched males throughout most of their life. However, after menopause the risk for heart failure in women rises until the difference between the sexes disappears by age 80. Ageing itself in an independent risk factor for heart failure and with populations throughout the world seeing significant increases in older demographics it is expected that the rates of heart failure will rise dramatically. Why pre-menopausal women are relatively protected against heart failure compared to age-matched men is unknown, as is the reason for the loss of protection after menopause. It has been speculated that estrogens contribute to the protection against heart failure, but the molecular mechanisms that mediate this effect remain unidentified. We have shown that hearts from aged male mice exhibit significant increases in the level of an actin binding protein called 'CapZ'. This decrease corresponds with a reduction in heart function. Interestingly, age-matched female mice show a reduction in CapZ protein in the heart along with normal heart function. Mice of both sexes that are engineered to have reduced levels of CapZ in the heart show no decline in heart function with ageing. We hypothesize that female mice decrease CapZ levels in the heart to protect against age-dependent cardiac dysfunction, whereas male mice are unable to do so. Our programme will determine how sex influences cardiac function in ageing mice, and assess the impact of sex and ageing on cardiac CapZ levels. We will also investigate CapZ regulatory elements including CapZIP, Hsc70 and BAG3 to determine if these factors play sex-dependent roles in CapZ regulation in the ageing heart. This research will advance our understanding of the influence sex mediates over heart function, identify the molecular basis for sex-dependent cardiac dysfunction in ageing mice, and establish the therapeutic potential of reducing CapZ to block cardiac decline and extend life.
Programme
Catalyst Grant: Sex as a Variable in Biomedical Research
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
339909
Name
Pyle Glen W
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Gender and Health
Theme2
Biomedical
Prcname2
Catalyst Grant: Sex as a Variable in Biomedical or Translational Research
Projecttitle
Sex and the Ageing Heart: The molecular basis for the functional decline and development of a novel therapeutic target
Programtype2
Operating Grants
Orgnameinp2
University of Guelph
Cihramount2
$149,358
Cihrequipment2
$0
Programname2
Catalyst Grant: Sex as a Variable in Biomedical Research
Keyworddelim
Ageing; Capz; Heart; Myofilament; Sex; Z-Disc
Abstract
Females have lower rates of heart failure compared to age-matched males throughout most of their life. However, after menopause the risk for heart failure in women rises until the difference between the sexes disappears by age 80. Ageing itself in an independent risk factor for heart failure and with populations throughout the world seeing significant increases in older demographics it is expected that the rates of heart failure will rise dramatically. Why pre-menopausal women are relatively protected against heart failure compared to age-matched men is unknown, as is the reason for the loss of protection after menopause. It has been speculated that estrogens contribute to the protection against heart failure, but the molecular mechanisms that mediate this effect remain unidentified. We have shown that hearts from aged male mice exhibit significant increases in the level of an actin binding protein called 'CapZ'. This decrease corresponds with a reduction in heart function. Interestingly, age-matched female mice show a reduction in CapZ protein in the heart along with normal heart function. Mice of both sexes that are engineered to have reduced levels of CapZ in the heart show no decline in heart function with ageing. We hypothesize that female mice decrease CapZ levels in the heart to protect against age-dependent cardiac dysfunction, whereas male mice are unable to do so. Our programme will determine how sex influences cardiac function in ageing mice, and assess the impact of sex and ageing on cardiac CapZ levels. We will also investigate CapZ regulatory elements including CapZIP, Hsc70 and BAG3 to determine if these factors play sex-dependent roles in CapZ regulation in the ageing heart. This research will advance our understanding of the influence sex mediates over heart function, identify the molecular basis for sex-dependent cardiac dysfunction in ageing mice, and establish the therapeutic potential of reducing CapZ to block cardiac decline and extend life.
Competitiondate
201511
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Pyle, Glen W
Approvedterm
2 ans 0 mois
Cihrcontribution2
Inst of Cancer Research~ $74,679~ $0~Inst of Gender & Health~ $74,679~ $0~